Fellow's research could spell breakthrough in treatment of heart disease
Published: 20 Aug 2015
Dr Rameen Shakur carried out his Fellowship into the application of molecular and genomic medicine in the prevention of heart disease as a medical student in 2001.
Now a cardiologist and clinical researcher, he has just had research published that could spell a breakthrough in the treatment of cardiovascular illness.
Rameen and his colleagues were interested in the potential applications of a newly-developed artificial membrane which provides more oxygen for cells. When they applied it to human stem cells, they found that the genes known to be responsible for causing oxygen deficiency (hypoxia) showed significantly reduced activity, an effect which can last for up to 14 days.
This technology opens brand new research avenues in cardiology, and there is the potential for it to have real impact on patient care and management.
Rameen will be presenting his findings as one of the keynote lecturers in this year’s International Conference on Nanotechnology in Medicine.